Otelixizumab
http://dbpedia.org/resource/Otelixizumab an entity of type: Thing
Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.
rdf:langString
rdf:langString
Otelixizumab
xsd:integer
12478287
xsd:integer
1102283625
rdf:langString
none
xsd:integer
6448
xsd:integer
881191
rdf:langString
none
xsd:integer
9954
rdf:langString
D08959
xsd:integer
1718
xsd:integer
2016
xsd:integer
42
rdf:langString
xizu/a
rdf:langString
mab
rdf:langString
I5HF2X04PB
rdf:langString
changed
xsd:integer
458269768
rdf:langString
changed
rdf:langString
Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.
rdf:langString
mab
xsd:nonNegativeInteger
7615
xsd:string
881191-44-2
xsd:string
I5HF2X04PB
xsd:string
D08959